To explore the shared molecular mechanisms and metabolic dysregulation in cancer and neurodegenerative diseases, focusing on the role of glycolysis.
Key Findings:
ACAA2 gene expression was downregulated in COAD and upregulated in PD, indicating an inverse relationship.
Aerobic glycolysis is crucial for cancer cell proliferation and offers neuroprotection in the brain.
Both cancer and neurodegenerative diseases share a set of genes with inverse regulatory patterns.
Interpretation:
The findings suggest that metabolic reprogramming, particularly involving glycolysis, may serve as a therapeutic target for both cancer and neurodegenerative diseases, highlighting a complex interplay between these conditions.
Limitations:
The study primarily focused on specific cancer types and neurodegenerative diseases, which may limit the generalizability of the findings.
Further research is needed to elucidate the exact mechanisms underlying the observed inverse gene expression patterns.
Conclusion:
Understanding the metabolic intersections between cancer and neurodegenerative disorders could lead to novel therapeutic strategies targeting glycolysis.
